510(k) Report

510(k) · Cleared

Cleared

ODFS Pace XL

K171396510(k) TraditionalCleared Jan 31, 2018265-day reviewClass II21 CFR 882.5810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Odstock Medical, Ltd. · GZI Stimulator, Neuromuscular, External Functional

Cleared on Jan 31, 2018 as substantially equivalent to K102115 (Odstock Medical, Ltd., 2011) and 1 other predicate after a 265-day review. Its family tree reaches back 4 generations to 1980.

Decided
Jan 31, 2018
Review
265 days
Class
Class II
Product code
GZI
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K800380 (1980). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK800380 Fes Orthosis Model NO. 2000Empi · 1980
  2. 3 generations backK974514 External Functional Neuromuscular StimulatorNeuromotion, Inc. · 1998
  3. 2 generations backK050991 The Odfs Dropped Foot StimulatorDepartment of Medical Physics and Biomedical Eng. · 2005
  4. 1 generation backK102115 Odfs PaceOdstock Medical, Ltd. · 2011
  5. This deviceK171396 ODFS Pace XLOdstock Medical, Ltd. · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K800380Fes Orthosis Model NO. 2000Empi1980—
−3K974514External Functional Neuromuscular StimulatorNeuromotion, Inc.1998—
−2K050991The Odfs Dropped Foot StimulatorDepartment of Medical Physics and Biomedical Eng.2005—
−1K102115Odfs PaceOdstock Medical, Ltd.2011—
0 (this device)K171396ODFS Pace XLOdstock Medical, Ltd.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198210
199110
199210
199610
FIG. 1 — Lineage of K171396, 1980–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GZI device

  1. #1 K243828 Cionic Neural Sleeve (NS-200)score 12.9 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K102115Odfs Pace
Summary page 5
…lass II Product Codes: GZI and IPF Predicate Devices Predicate Device K number Comment ODFS® Pace K102115 Odstock Medical Ltd ODFS® III V6.2 K050991 Odstock Medical Ltd (transferred from…
Odstock Medical, Ltd.2011—
*K050991The Odfs Dropped Foot Stimulator
Summary page 5
…vices Predicate Device K number Comment ODFS® Pace K102115 Odstock Medical Ltd ODFS® III V6.2 K050991 Odstock Medical Ltd (transferred from Salisbury District Hospital) Device Descri…
Department of Medical Physics and Biomedical Eng.2005—

Also cleared against K102115: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 38 years and passes through 4 companies; a new generation was cleared every 7.4 years on median.
  • None of the 8 ancestors has a recall.
  • 1 other device also cites its predicate K102115.

How does its category compare?

All GZI devices

GZI Stimulator, Neuromuscular, External Functional: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · GZI

2in 2025

2007: 42008: 12009: 12011: 62012: 22013: 22014: 32015: 12016: 12017: 62018: 22019: 22020: 22021: 12022: 42023: 12024: 22025: 2
2007high 6 (2011) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GZI

110in 2022

2007: 81 days median2011: 139 days median2014: 299 days median2017: 168 days median2022: 110 days median
2007high 299 (2014) · low 81 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GZI

1in 2008

2008: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GZI

3in 2025

2007: 12008: 22009: 82010: 12011: 32012: 22014: 22015: 32017: 22018: 12019: 42021: 12022: 32023: 12024: 12025: 3
2007high 8 (2009) · low 0 (2013)2025

MAUDE reports naming product code GZI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200748101
20081—12
20091—08
20100—01
2011613903
20122—02
20132—00
2014329902
20151—03
20161—00
2017616802
20182—01
20192—04
20202—00
20211—01
2022411003
20231—01
20242—01
20252—03
20260—0—

What is it indicated for?

The ODFS® Pace XL is intended to provide ankle dorsiflexion in individuals who have a dropped foot as a consequence of upper motor neuron injury. By detecting the swing phase of gait through a foot switch signal, appropriate electrical stimulation of the leg and ankle muscles may improve gait by flexing the foot of persons who have lost or impaired function. There may be additional benefits from FES such as muscle re-education, prevention/retardation of…

Read the full statement (117 words)

The ODFS® Pace XL is intended to provide ankle dorsiflexion in individuals who have a dropped foot as a consequence of upper motor neuron injury. By detecting the swing phase of gait through a foot switch signal, appropriate electrical stimulation of the leg and ankle muscles may improve gait by flexing the foot of persons who have lost or impaired function. There may be additional benefits from FES such as muscle re-education, prevention/retardation of disuse atrophy, increased or maintained range of joint motion and increase in local blood flow.

The ODFS® Pace XL is a medical device and should only be used under medical supervision for the treatment of dropped foot following an upper motor neuron injury.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K171396: ODFS Pace XL.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K171396

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026